Newsroom
CV6 Therapeutics Founder Shortlisted for Business Post CEO of the Year Award
Dr. Robert D. Ladner has been shortlisted alongside nine business leaders from across the island of Ireland after building CV6 into a GUSR platform company whose first-in-class lead oncology candidate is advancing through a first-in-human Phase 1a clinical trial.
AIB Business Eye Award Nominations Recognise CV6 Innovation, Growth and Leadership
Organized by Northern Ireland business magazine Business Eye in partnership with AIB, the awards are marking their 20th year of recognizing achievement, innovation and leadership across the region’s business community.
HIRANI Spotlights CV6’s Belfast Biotechnology Story
From Discovery to Clinical Development: CV6 grew from an original scientific idea into a clinical-stage biotechnology company, the Northern Ireland ecosystem supporting that journey, and the company’s work across cancer and inflammatory disease.
BBC Radio Foyle Interview with CV6 CEO and Founder
Dr. Robert Ladner joins Mark Patterson in the studio, to discuss his work to improve outcomes for cancer patients and what has brought him to the place of his roots, the Northwest.
CV6 Named Finalist in Two Belfast Chamber Business Awards in Partnership With Bank of Ireland
CV6 is a finalist for Business Innovation, sponsored by Kingsbridge Healthcare Group, and Team of the Year, sponsored by Cathedral Quarter BID.
QUBIS Features Bob Ladner on Building CV6 in Belfast
The people, partnerships and persistence behind CV6’s journey from Southern California to Belfast, and from promising science into clinical development.